☆ 4.7 Article

Hidden Potential of Highly Efficient and Widely Accessible Thrombolytic Staphylokinase

STROKE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Tools for computational design and high-throughput screening of therapeutic enzymes

Michal Vasina et al.

Summary: Therapeutic enzymes are valuable biopharmaceuticals that have found successful applications in various biomedical fields. The integration of computational approaches and high-throughput experimental technologies has greatly accelerated the identification and engineering of catalytic therapeutic agents, leading to the discovery of new enzymes and the improvement of their properties.

ADVANCED DRUG DELIVERY REVIEWS (2022)

添加到收藏夹

Review Emergency Medicine

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review

Neha Potla et al.

Summary: According to the available evidence, tenecteplase appears to be a better thrombolytic agent for acute ischemic stroke compared to alteplase.

INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE (2022)

添加到收藏夹

Review Clinical Neurology

Mobile Stroke Units: Evidence, Gaps, and Next Steps

Babak B. Navi et al.

Summary: Mobile stroke units (MSUs) are specialized ambulances equipped to diagnose and treat acute stroke in prehospital settings. Recent clinical trials have shown that treatment aboard MSUs is safe and leads to improved functional outcomes. However, questions remain regarding the cost-effectiveness of MSUs, their utility in nonurban settings, and optimal infrastructure.

STROKE (2022)

添加到收藏夹

Article Chemistry, Physical

Extended Mechanism of the Plasminogen Activator Staphylokinase Revealed by Global Kinetic Analysis: 1000-fold Higher Catalytic Activity than That of Clinically Used Alteplase

Martin Toul et al.

Summary: This study provides a detailed understanding of the biochemical mechanism and limiting steps of the plasminogen activator staphylokinase, and determines its high catalytic activity. This knowledge is crucial for fully understanding its catalytic functionality and designing rational engineering strategies.

ACS CATALYSIS (2022)

添加到收藏夹

Article Clinical Neurology

Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Valery L. Feigin et al.

Summary: Regularly updated data on stroke including incidence, prevalence, mortality, disability, risk factors, and trends are crucial for evidence-based care planning. The Global Burden of Diseases Study provides comprehensive measurement of these metrics. From 1990 to 2019, while age-standardized rates improved, the number of strokes and deaths increased. Low-income countries had the highest stroke-related mortality and DALY rates, with high body-mass index being the fastest-growing risk factor.

LANCET NEUROLOGY (2021)

添加到收藏夹

Review Clinical Neurology

Development and Testing of Thrombolytics in Stroke

Dmitri Nikitin et al.

Summary: Although mechanical thrombectomy has advanced, it will not be a universal treatment for ischemic stroke due to limited access, leaving thrombolytic therapy as an important option for hyperacute stroke. Improvements are needed in thrombolytic drugs to increase efficacy and decrease hemorrhagic complications.

JOURNAL OF STROKE (2021)

添加到收藏夹

Editorial Material Clinical Neurology

A new thrombolytic drug for acute ischaemic stroke

Peter M. Rothwell et al.

LANCET NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial

Eugene Gusev et al.

Summary: The study showed that non-immunogenic staphylokinase was non-inferior to alteplase in patients with acute ischemic stroke, with comparable overall and safety outcomes. Future research is needed to further evaluate the efficacy and safety of non-immunogenic staphylokinase in patients with acute ischemic stroke within and outside the 4.5-hour time window.

LANCET NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Burden of Stroke in Europe Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years

Hatem A. Wafa et al.

STROKE (2020)

添加到收藏夹

Review Clinical Neurology

Tenecteplase Thrombolysis for Acute Ischemic Stroke

Steven J. Warach et al.

STROKE (2020)

添加到收藏夹

Review Clinical Neurology

Emerging Areas of Stroke Rehabilitation Research in Low- and Middle-Income Countries A Scoping Review

Janet Prvu Bettger et al.

STROKE (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Structural Biology and Protein Engineering of Thrombolytics

Jan Mican et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)

添加到收藏夹

Article Clinical Neurology

Cost of Alteplase Has More Than Doubled Over the Past Decade

Dawn Kleindorfer et al.

STROKE (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Therapeutic Fibrinolysis How Efficacy and Safety Can Be Improved

Victor Gurewich

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

添加到收藏夹

Review Clinical Neurology

Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability

Bruce C. V. Campbell et al.

STROKE (2015)

添加到收藏夹

Article Medicine, General & Internal

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Jonathan Emberson et al.

LANCET (2014)

添加到收藏夹

Review Clinical Neurology

Socioeconomic Status and Stroke An Updated Review

Juliet Addo et al.

STROKE (2012)

添加到收藏夹

Review Clinical Neurology

Safety of Thrombolysis in Acute Ischemic Stroke: A Review of Complications, Risk Factors, and Newer Technologies

Daniel J. Miller et al.

NEUROHOSPITALIST (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.